atazanavir

Generic: atazanavir

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name atazanavir
Generic Name atazanavir
Labeler camber pharmaceuticals, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

atazanavir sulfate 300 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-655
Product ID 31722-655_30891c38-5d64-7df7-e063-6394a90ae762
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212278
Listing Expiration 2026-12-31
Marketing Start 2022-02-07

Pharmacologic Class

Classes
cytochrome p450 2c8 inhibitors [moa] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] hiv protease inhibitors [moa] protease inhibitor [epc] udp glucuronosyltransferases inhibitors [moa] ugt1a1 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722655
Hyphenated Format 31722-655

Supplemental Identifiers

RxCUI
402246 402247 664741
UPC
0331722654609 0331722653602 0331722655309
UNII
4MT4VIE29P

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name atazanavir (source: ndc)
Generic Name atazanavir (source: ndc)
Application Number ANDA212278 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 500 CAPSULE in 1 BOTTLE (31722-655-05)
  • 30 CAPSULE in 1 BOTTLE (31722-655-30)
  • 100 BLISTER PACK in 1 CARTON (31722-655-31) / 10 CAPSULE in 1 BLISTER PACK
source: ndc

Packages (3)

31722-655-05 500 CAPSULE in 1 BOTTLE (31722-655-05) 31722-655-30 30 CAPSULE in 1 BOTTLE (31722-655-30) 31722-655-31 100 BLISTER PACK in 1 CARTON (31722-655-31) / 10 CAPSULE in 1 BLISTER PACK

Ingredients (1)

atazanavir sulfate (300 mg/1)

Linked Drug Pages (1)

Atazanavir ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "30891c38-5d64-7df7-e063-6394a90ae762", "openfda": {"upc": ["0331722654609", "0331722653602", "0331722655309"], "unii": ["4MT4VIE29P"], "rxcui": ["402246", "402247", "664741"], "spl_set_id": ["8a0c609f-e296-4925-a35c-e93a04467655"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE in 1 BOTTLE (31722-655-05)", "package_ndc": "31722-655-05", "marketing_start_date": "20220207"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (31722-655-30)", "package_ndc": "31722-655-30", "marketing_start_date": "20220207"}, {"sample": false, "description": "100 BLISTER PACK in 1 CARTON (31722-655-31)  / 10 CAPSULE in 1 BLISTER PACK", "package_ndc": "31722-655-31", "marketing_start_date": "20220207"}], "brand_name": "Atazanavir", "product_id": "31722-655_30891c38-5d64-7df7-e063-6394a90ae762", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "31722-655", "generic_name": "Atazanavir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atazanavir", "active_ingredients": [{"name": "ATAZANAVIR SULFATE", "strength": "300 mg/1"}], "application_number": "ANDA212278", "marketing_category": "ANDA", "marketing_start_date": "20220207", "listing_expiration_date": "20261231"}